Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SCNI | AMGN | VRTX | BMY | GILD |
| Company | Scinai Immunotherapeutics Ltd ADR | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 3.70 | 316.16 | 483.00 | 55.14 | 89.64 |
| High | 3.70 | 319.52 | 503.21 | 56.24 | 90.39 |
| Low | 3.61 | 313.02 | 474.00 | 54.72 | 89.01 |
| Last | 3.66 | 318.66 | 499.17 | 56.15 | 90.25 |
| Change | unch | +1.75 | +26.37 | +0.70 | +0.41 |
| % Change | +0.14% | +0.55% | +5.58% | +1.26% | +0.46% |
| Volume | 1,728 | 593,612 | 946,028 | 4,266,093 | 1,816,504 |
| 20-Day Average Volume | 11,046 | 1,675,626 | 1,029,450 | 8,445,726 | 5,042,505 |
| Previous Close | 3.65 | 316.91 | 472.80 | 55.45 | 89.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.65 | 319.65 | 478.84 | 53.25 | 87.52 |
| 20-Day Raw Stochastic | 40.34% | 39.20% | 97.91% | 99.29% | 93.12% |
| 20-Day Relative Strength | 49.93% | 46.63% | 60.32% | 64.66% | 69.91% |
| Weighted Alpha | -43.77 | +16.06 | +32.22 | +19.01 | +27.72 |
| Today's Opinion | 56% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 80% Sell | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 24% Buy | 8% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.09% since 10/29/24 | +0.88% since 10/29/24 | +5.97% since 10/29/24 | +7.02% since 10/29/24 | +2.48% since 10/29/24 |
| Low | 3.51 on 10/30/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 52.29 on 10/30/24 | 87.48 on 10/30/24 |
| High | 3.72 on 10/31/24 | 323.40 on 10/31/24 | 499.36 on 11/05/24 | 56.24 on 11/05/24 | 90.71 on 11/04/24 |
| 1-Month | |||||
| %Chg | +0.41% since 10/04/24 | -0.28% since 10/04/24 | +9.48% since 10/04/24 | +4.12% since 10/04/24 | +6.70% since 10/04/24 |
| Low | 3.35 on 10/24/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 |
| High | 4.11 on 10/21/24 | 329.17 on 10/11/24 | 499.36 on 11/05/24 | 56.24 on 11/05/24 | 90.71 on 11/04/24 |
| 3-Month | |||||
| %Chg | +1.29% since 08/05/24 | -1.98% since 08/05/24 | +4.52% since 08/05/24 | +18.06% since 08/05/24 | +20.62% since 08/05/24 |
| Low | 3.30 on 09/20/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 4.76 on 09/18/24 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 56.24 on 11/05/24 | 90.71 on 11/04/24 |
| 6-Month | |||||
| %Chg | -21.58% since 05/03/24 | +2.41% since 05/03/24 | +24.28% since 05/03/24 | +27.72% since 05/03/24 | +39.33% since 05/03/24 |
| Low | 2.23 on 06/10/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 8.92 on 07/15/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.24 on 11/05/24 | 90.71 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,121 | 170,284,928 | 122,030,624 | 112,462,416 | 111,850,072 |
| Shares Outstanding, K | 581 | 537,329 | 258,102 | 2,028,177 | 1,244,992 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -6,500,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 280,000 | 8,503,000,000 | 2,645,600,000 | 11,892,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -2,320,000 | 2,830,000,000 | -3,593,600,000 | 1,211,000,000 | 1,614,000,000 |
| 60-Month Beta | 2.46 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.57 on 08/15/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/05/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 0.00 | 46.43 | 19.04 |